Results 301 to 310 of about 1,112,203 (348)
Some of the next articles are maybe not open access.
Non-opioid actions of opioid peptides
Life Sciences, 2004Beside the well known actions of opioid peptides on mu-, delta- and kappa-opioid receptors, increasing amount of pharmacological and biochemical evidence has recently been published about non-opioid actions of various opioid peptides. These effects are not abolished by naloxone treatments.
Maria Wollemann, Sándor Benyhe
openaire +3 more sources
Development of opioid peptide analogs for pain relief.
Current pharmaceutical design, 2010Opioid receptors and opioid peptides constitute the endogenous opioid system. The most relevant function of the opioid system seems to be the inhibitory modulation of nociceptive information at supraspinal, spinal and peripheral sites, although it is ...
A. Janecka +4 more
semanticscholar +1 more source
Biosynthesis and distribution of opioid peptides [PDF]
Journal of Endocrinological Investigation, 1983 Group III opioid peptides are derived from proenkephalin B. The processing of this precursor peptide is still only partly understood and we still do not know how many final products come from proenkephalin B and whether Leu-enkephalin is produced from Group III peptides.
I. Tanaka +10 more
openaire +2 more sources
Endotoxin-stimulated opioid peptide secretion: two secretory pools and feedback control in vivo.
Science, 1982Small doses of endotoxin evoked a dramatic biphasic response of opioid peptide secretion into blood in sheep. The first phase began within minutes and coincided with a brief hypertensive response to endotoxin well before the appearance of fever or ...
Daniel B. Carr +7 more
semanticscholar +1 more source
The opioid peptide dynorphin, circadian rhythms, and starvation.
Science, 1983Dynorphin, an opioid peptide whose functions are unknown, is found in brain, pituitary, and peripheral organs. Specific radioimmunoassays were used to measure dynorphin in the hypothalamus and pituitary, during the day and at night, as a function of food
R. Przewłocki +5 more
semanticscholar +1 more source
Progestins increase endogenous opioid peptide activity in postmenopausal women.
Journal of Clinical Endocrinology and Metabolism, 1985To determine the effect of administration of a progestin alone on endogenous opioid peptide activity, we infused naloxone (2 mg/h for 4 h) into seven estrogen-deficient postmenopausal women before and after oral medroxyprogesterone acetate (Provera; 20 ...
R. Casper, S. Alapin-Rubillovitz
semanticscholar +1 more source
Expression of Opioid Peptides in Tumors
New England Journal of Medicine, 1987We looked for opioid peptides and their precursors in 108 tumors of both neuroendocrine and nonneuroendocrine origin, using a monoclonal "pan-opioid" antibody, 3-E7, which recognizes the tetrapeptide Tyr-Gly-Gly-Phe (the sequence responsible for pharmacologic activity in all known opioid peptides), in conjunction with polyclonal antibodies directed ...
Klaus G. Bensch +5 more
openaire +3 more sources
Biosynthesis of Opioid Peptides
1990The endogenous opioid peptides all contain the enkephalin sequence Tyr-Gly-Gly-Phe-Met and Tyr-Gly-Gly-Phe-Leu at their aminoterminus. Three distinct families of these peptides (endorphins, enkephalins and dynorphins) are present in different neuronal pathways within the central nervous system. Molecular genetics have shown that these three families of
openaire +3 more sources
Chapter 18 Nicotine and opioid peptides
1989Publisher Summary This chapter discusses the relationship between nicotinic cholinergic receptors and opioid peptides. Nicotine appears to exert its stimulatory effect most likely at the level of the hypothalamus by causing a release of corticotropin releasing factor.
Gabriele Horn, V. Höllt
openaire +3 more sources
Endomorphins and related opioid peptides
2002Opioid peptides and their G-protein-coupled receptors (delta, kappa, mu) are located in the central nervous system and peripheral tissues. The opioid system has been studied to determine the intrinsic mechanism of modulation of pain and to develop uniquely effective pain-control substances with minimal abuse potential and side effects.
Sharon D. Bryant +3 more
openaire +3 more sources